Re-evaluating prognosis of subungual melanoma: a comparison with non-subungual acral lentiginous melanoma
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf310 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Che-Chia Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Nail Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Ministry of Science and Technology of Taiwan, National Science and Technology Council, National Taiwan University Hospital.
Abstract (Originalsprache)
Background
The clinicopathological characteristics and survival outcomes of subungual melanoma remain unclear, with previous studies showing conflicting results.
Objectives
We aimed to elucidate the clinicopathological features and survival outcomes of subungual melanoma and compare them with those of non-subungual acral lentiginous melanoma (ALM).
Methods
A retrospective cohort study was conducted, analysing data from patients with ALM diagnosed between June 1980 and June 2024 at the National Taiwan University Hospital.
Results
Among the 342 patients with ALM included in our study, 70 (20.5%) had subungual melanoma. Compared with patients with non-subungual melanoma, the subungual group had a higher proportion of younger patients and fewer patients presenting with advanced initial stages. The 5-year melanoma-specific survival (MSS) was 82.3% for subungual melanoma vs. 65.7% for non-subungual melanoma (log-rank P = 0.02). However, multivariate analysis revealed that only traditional staging-related factors and the year of diagnosis, rather than a subungual location, were significantly associated with MSS.
Conclusions
While subungual melanoma appears to have a favourable prognosis, our findings suggest that this may primarily be attributable to confounding factors such as staging and improvements in prognosis over time. A subungual location itself may not represent an independent prognostic factor. Advances in treatments and diagnostic procedures may have both contributed to the overall improvement in ALM prognosis observed since 2010 in this real-world study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Medical Education, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsin-chu, Taiwan.
- Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
ORCID-Profile: Che-Chia Hsu
Förderung
- Ministry of Science and Technology of Taiwan
- National Science and Technology Council
- National Taiwan University Hospital
Zitieren
APA
Hsu, C. C., Lee, Y., Liao, Y. H., Lin, M. H., Liau, J. Y., Chu, C. Y., & Sheen, Y. S. (2025). Re-evaluating prognosis of subungual melanoma: a comparison with non-subungual acral lentiginous melanoma. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf310
Vancouver
Hsu CC, Lee Y, Liao YH, Lin MH, Liau JY, Chu CY, et al. Re-evaluating prognosis of subungual melanoma: a comparison with non-subungual acral lentiginous melanoma. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf310
BibTeX
@article{Hsu2025,
author = {Hsu, Che-Chia and Lee, Yang and Liao, Yi-Hua and Lin, Ming-Hsien and Liau, Jau-Yu and Chu, Chia-Yu and Sheen, Yi-Shuan},
title = {Re-evaluating prognosis of subungual melanoma: a comparison with non-subungual acral lentiginous melanoma},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf310}
}
EUVIMED